Rare diseases
Investigational molecules
Locations
Study of nirmatrelvir and remdesivir to achieve viral clearance in immunocompromised patients with persistent COVID-19
GermanyStudy of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems
SwedenA study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants
BelgiumStudy on the Use of Casirivimab, Cilgavimab, Sotrovimab, and Nirmatrelvir for Patients with COVID-19 Infection
The NetherlandsStudy on the Safety and Effectiveness of Nirmatrelvir and Ritonavir for Nonhospitalized Children with COVID-19 at Risk of Severe Illness
BulgariaStudy of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway
NorwayStudy on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients
FranceStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
